Restoration of visual function in advanced disease after transplantation of purified human pluripotent stem cell-derived cone photoreceptors
Author(s) -
Joana Ribeiro,
Christopher A. Procyk,
Emma L. West,
Michelle O’Hara-Wright,
Monica F. Martins,
Majid Moshtagh Khorasani,
Aura Hare,
Mark Basche,
Milan Fernando,
Debbie Goh,
Neeraj Jumbo,
Matteo Rizzi,
Kate Powell,
Menahil Tariq,
Michel Michaelides,
James Bainbridge,
Alexander J. Smith,
R. A. Pearson,
Anai Gonzalez-Cordero,
Robin R. Ali
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109022
Subject(s) - neuroscience , transplantation , induced pluripotent stem cell , biology , retina , retinal degeneration , retinal , macular degeneration , ophthalmology , medicine , embryonic stem cell , surgery , genetics , biochemistry , gene
Summary Age-related macular degeneration and other macular diseases result in the loss of light-sensing cone photoreceptors, causing irreversible sight impairment. Photoreceptor replacement may restore vision by transplanting healthy cells, which must form new synaptic connections with the recipient retina. Despite recent advances, convincing evidence of functional connectivity arising from transplanted human cone photoreceptors in advanced retinal degeneration is lacking. Here, we show restoration of visual function after transplantation of purified human pluripotent stem cell-derived cones into a mouse model of advanced degeneration. Transplanted human cones elaborate nascent outer segments and make putative synapses with recipient murine bipolar cells (BCs), which themselves undergo significant remodeling. Electrophysiological and behavioral assessments demonstrate restoration of surprisingly complex light-evoked retinal ganglion cell responses and improved light-evoked behaviors in treated animals. Stringent controls exclude alternative explanations, including material transfer and neuroprotection. These data provide crucial validation for photoreceptor replacement therapy and for the potential to rescue cone-mediated vision.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom